Due to these multi-faceted features of PD-L1 on the vascular endothelium, a careful measure must be taken to manipulate PD-L1 for therapeutic immune modulatory purposes on atherosclerosis-associated blood vessel inflammatory diseases. Here, CD274 is linked to atherosclerosis.